PRPH
ProPhase Labs, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.02
+17.65%Aug 6, 2026, 00:00 UTC
ProPhase Labs signed a $2,085,000 senior secured convertible installment promissory note, receiving $1,500,000 in gross funding and $1,020,000 in net closing proceeds for working capital, repayable in weekly $20,000 installments and convertible into common stock at $0.075 per share.